Delivery Order SPE2DB22D2206-SPE2DB25FFM00

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,460.32 firm fixed-price delivery order is for FLAREX 0.1% eye drops, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,170.83 firm fixed-price delivery order is for the supply of 4566416958 FLAREX 0.1% eye drops, 5 ML. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,838.84 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product used for ophthalmic treatment. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen is the prime contractor and there are no set-aside requirements indicated. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of FLAREX 0.1% eye drops. The $24,958.18 firm fixed-price delivery order contract has a completion date of November 22, 2024 and was awarded on November 21, 2024. It is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of FLAREX 0.1% Eye Drops 5ML to the Defense Logistics Agency (DLA), a defense agency. The $3,227.47 firm fixed price delivery order is issued under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,377.76 firm-fixed-price contract is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product, to support military treatment facilities and healthcare programs. The contract has a period of performance through July 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, holding...
This is a delivery order for $10,832.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide FLAREX 0.1% eye drops. The contract has a firm fixed price and a completion date of September 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities, including...
This federal contract award, valued at $4,468.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of FLAREX 0.1% eye drops (5ml) and has an ultimate completion date of June 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,247.52 Firm Fixed Price Delivery Order is for the supply of FLUOROMETHOLONE 0.1% EYE DROP 10ML, a specialty medication. The contract has an ultimate completion date of April 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFM00
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,646.46 firm fixed-price delivery order is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/7/25, 9:55 AM